Eyemarker Systems, Inc   Report issue

For profit
Founded: Morgantown WV United States (2001)
Status: Defunct (2018)

Organization Overview

First Clinical Trial
2010
NCT01066923
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2010

Timeline

NOW
  • Now

Active Ingredients

Drugs in Other Trials (2)

acetylsalicylic acid (aspirin) (1 trial)

sodium chloride (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 1
  • # of Trial APIs: 2